Ichiro Nakano

Stem cell-derived neural stem/progenitor cell supporting factor is an autocrine/paracrine survival factor for adult neural stem/progenitor cells.

Cancerous stem cells can arise from pediatric brain tumors.

Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations.

Patterns of Jagged1, Jagged2, Delta-like 1 and Delta-like 3 expression during late embryonic and postnatal brain development suggest multiple functional roles in progenitors and differentiated cells.

Developmental expression of glial fibrillary acidic protein mRNA in mouse forebrain germinal zones--implications for stem cell biology.

[Cancer stem cells in pediatric brain tumors].

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation.

Phenotypic and functional heterogeneity of GFAP-expressing cells in vitro: differential expression of LeX/CD15 by GFAP-expressing multipotent neural stem cells and non-neurogenic astrocytes.

Brain tumor stem cells.

Phosphoserine phosphatase is expressed in the neural stem cell niche and regulates neural stem and progenitor cell proliferation.

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.

BMPing off glioma stem cells.

Trifluoromethoxy-benzylated ligands improve amyloid detection in the brain using (19)F magnetic resonance imaging.

Cancer stem cells in pediatric brain tumors.

Methods for analysis of brain tumor stem cell and neural stem cell self-renewal.

Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease.

[Cancer stem cells in malignant glioma-the mechanism of cancer initiation and the therapeutic development].

Finding drugs against CD133+ glioma subpopulations.

Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.

A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.

CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.

Hope and Challenges for Dendritic Cell-Based Vaccine Therapy for Glioblastoma.

Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.